{
    "Trade/Device Name(s)": [
        "ADVOCATE REDI-CODE DASH Blood Glucose Monitoring System",
        "ADVOCATE REDI-CODE DASH Blood Glucose Monitoring System, Model TD-4276"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K093940",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072039"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 12, 2010",
    "Summary Letter Received Date": "April 14, 2010",
    "Submission Date": "December 21, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVOCATE REDI-CODE DASH Blood Glucose Meter, Model TD-4276"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for ADVOCATE REDI-CODE DASH Blood Glucose Monitoring System, an electrochemical glucose test system for home and professional use.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites (palm, forearm, upper-arm, calf, thigh); aids in monitoring diabetes control in home and professional settings; not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}